Form EFFECT NLS Pharmaceutics Ltd.

November 27, 2024 6:03 AM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 26, 2024 4:30 P.M.
Form: F-3
CIK: 0001783036
Company Name: NLS Pharmaceutics Ltd.
File Number: 333-282788


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings